← Open Payments lookup

NPI 1386736627: Open Payments

NPI 1386736627. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$687 in 29 payments from 7 companies in 2025. Trend: 2023 $1,704 · 2024 $1,048 · 2025 $687

Food & beverage: $681Education: $5
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$270
Janssen Pharmaceuticals, Inc10$206
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$81
Teva Pharmaceuticals USA, Inc.4$72
Vanda Pharmaceuticals Inc.1$24
Alkermes, Inc.1$19
ABBVIE INC.1$15

Products named: ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, REXULTI, AUSTEDO XR, UZEDY, SPRAVATO, ABILIFY ASIMTUFII.